Functional roles of the tyrosine within the NP(X)nY motif and the cysteines in the C-terminal juxtamembrane region of the CB2 cannabinoid receptor

被引:24
作者
Feng, WK [1 ]
Song, ZH [1 ]
机构
[1] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA
关键词
cannabinoid receptor 2; cannabinoid; site-directed mutagenesis; structure; function;
D O I
10.1016/S0014-5793(01)02642-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In G protein-coupled receptors, a NP(X)(n)Y motif in the seventh transmembrane domain and cysteine residues in the C-terminal juxtamembrane region are conserved. In the current study the roles of Y299 within the NPVIY motif and C313 and C320 in the C-terminal juxtamembrane region of the human CB2 cannabinoid receptor were investigated by site-directed mutagenesis. Replacing Y299 with alanine resulted in a complete loss of ligand binding and a severe impairment of cannabinoid-induced inhibition of forskolin-stimulated cAMP accumulation. The C313A and C320A mutations markedly reduced functional coupling to adenylate, cyclase, but had no effect on ligand binding and agonist-induced receptor desensitization. (C) 2001 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:166 / 170
页数:5
相关论文
共 23 条
[1]   STRUCTURE AND FUNCTION OF RECEPTORS COUPLED TO G-PROTEINS [J].
BALDWIN, JM .
CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (02) :180-190
[2]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[3]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[4]   CALCULATING RECEPTOR NUMBER FROM BINDING EXPERIMENTS USING SAME COMPOUND AS RADIOLIGAND AND COMPETITOR [J].
DEBLASI, A ;
OREILLY, K ;
MOTULSKY, HJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (06) :227-229
[5]   Cannabinoid receptors and their endogenous agonists [J].
Felder, CC ;
Glass, M .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1998, 38 :179-200
[6]  
FELDER CC, 1995, MOL PHARMACOL, V48, P443
[7]  
FELDER CC, 1992, MOL PHARMACOL, V42, P838
[8]   Mutations of Tyr(326) in the beta(2)-adrenoceptor disrupt multiple receptor functions [J].
Gabilondo, AM ;
Krasel, C ;
Lohse, MJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 307 (02) :243-250
[9]   EXPRESSION OF CENTRAL AND PERIPHERAL CANNABINOID RECEPTORS IN HUMAN IMMUNE TISSUES AND LEUKOCYTE SUBPOPULATIONS [J].
GALIEGUE, S ;
MARY, S ;
MARCHAND, J ;
DUSSOSSOY, D ;
CARRIERE, D ;
CARAYON, P ;
BOUABOULA, M ;
SHIRE, D ;
LEFUR, G ;
CASELLAS, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 232 (01) :54-61
[10]  
HOWLETT AC, 1986, MOL PHARMACOL, V29, P307